Sanofi SA
PAR:SAN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
PAR:SAN
Watchlist
Price: 82.29 EUR 1.35% Market Closed
Market Cap: 101B EUR

Relative Value

The Relative Value of one SAN stock under the Base Case scenario is hidden EUR. Compared to the current market price of 82.29 EUR, Sanofi SA is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SAN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
39
Median 3Y
2.6
Median 5Y
2.7
Industry
2.6
Forward
2.2
vs History
96
vs Industry
21
Median 3Y
14.3
Median 5Y
15.3
Industry
21.4
Forward
10.4
vs History
98
vs Industry
27
Median 3Y
11
Median 5Y
11.6
Industry
16.4
vs History
98
vs Industry
21
Median 3Y
17.4
Median 5Y
19.5
Industry
22.8
vs History
98
vs Industry
45
Median 3Y
1.5
Median 5Y
1.6
Industry
2.2
vs History
93
vs Industry
37
Median 3Y
2.7
Median 5Y
2.9
Industry
2.9
Forward
2.3
vs History
98
vs Industry
45
Median 3Y
3.9
Median 5Y
4.1
Industry
5.5
vs History
93
vs Industry
33
Median 3Y
8.6
Median 5Y
9
Industry
13
Forward
7.5
vs History
93
vs Industry
30
Median 3Y
11.4
Median 5Y
13
Industry
16.5
Forward
9.1
vs History
98
vs Industry
26
Median 3Y
11.7
Median 5Y
12.3
Industry
15.6
vs History
98
vs Industry
15
Median 3Y
14.7
Median 5Y
15.8
Industry
18.7
vs History
82
vs Industry
47
Median 3Y
1.1
Median 5Y
1.1
Industry
1.9

Multiples Across Competitors

SAN Competitors Multiples
Sanofi SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Sanofi SA
PAR:SAN
100.1B EUR 1.5 7.3 6.6 6.6
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.9 54.7 36.7 39.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
492.8B USD 5.3 19.6 16.1 20.8
CH
Roche Holding AG
SIX:ROG
262.7B CHF 4.3 27.9 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
217.7B GBP 5.1 31.3 108.6 158.9
CH
Novartis AG
SIX:NOVN
214B CHF 4.8 18.7 11.8 15.3
US
Merck & Co Inc
NYSE:MRK
270.8B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.1 15.6 10.8 12.6
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
144.6B USD 2.3 14.7 7.5 10.2
P/E Multiple
Earnings Growth PEG
FR
Sanofi SA
PAR:SAN
Average P/E: 22.7
7.3
26%
0.3
US
Eli Lilly and Co
NYSE:LLY
54.7
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.6
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.9
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.3
37%
0.8
CH
Novartis AG
SIX:NOVN
18.7
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
15.6
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.7
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Sanofi SA
PAR:SAN
Average EV/EBITDA: 400.5
6.6
8%
0.8
US
Eli Lilly and Co
NYSE:LLY
36.7
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.6
10%
10.9
CH
Novartis AG
SIX:NOVN
11.8
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Sanofi SA
PAR:SAN
Average EV/EBIT: 1 712.8
6.6
15%
0.4
US
Eli Lilly and Co
NYSE:LLY
39.3
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.8
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.9
23%
6.9
CH
Novartis AG
SIX:NOVN
15.3
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.6
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5